In the first part of a two-part series, Ann Harrison interviews addiction treatment expert Dr. Howard Kornfeld about the FDA decision to reject the Lykos Therapeutics proposal for MDMA-assisted therapy.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
The FDA has rejected Lykos Therapeutics’ New Drug Application for MDMA-assisted therapy for PTSD and requested an additional Phase 3 study.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
As Lykos Therapeutics awaits an FDA decision this week on its proposed MDMA-assisted therapy for PTSD, the company has announced new initiatives and measures for additional oversight if the therapy is approved.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
